Annie Yoshiyama

VP, Finance and CAO, Tricida.

Companies

Allogene Therapeutics, Inc.SVP, Finance Jun 11, 2024 to now¹
TricidaVP, Finance and CAO Dec 8, 2020 to Aug 9, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Allogene Therapeutics, Inc. ALLO124,517 shares³$159.6K at $1.28Apr 21, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Apr 21, 2026Sold 9,586 shares at $2.31 of Allogene Therapeutics, Inc.³
Feb 2, 2026Sold 4,167 shares at $1.72 of Allogene Therapeutics, Inc.⁴
Apr 21, 2025Sold 9,601 shares at $1.41 of Allogene Therapeutics, Inc.⁵
Jan 24, 2025Granted 36,232 shares of Allogene Therapeutics, Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAllogene Therapeutics, Inc., SVP, Finance
2
SEC EDGARTricida, VP, Finance and CAO
3
SEC EDGARAllogene Therapeutics, Inc. shares after the filing of Apr 21, 2026
4
SEC EDGARForm 4 filed Feb 4, 2026
5
SEC EDGARForm 4 filed Apr 23, 2025
6
SEC EDGARForm 4 filed Jan 28, 2025